2020-04-08
Lucence Diagnostics, a precision oncology company specializing in the development of non-invasive blood tests that achieve early cancer detection and improve treatment selection, has addressed a major issue regarding the management of the ongoing coronavirus outbreak by developing a nanotechnology-enabled sample collection medical device that allows for keeping COVID-19 RNA samples stable at...